Literature DB >> 28049762

The tyrosine kinase Src promotes phosphorylation of the kinase TBK1 to facilitate type I interferon production after viral infection.

Xuelian Li1, Mingjin Yang1, Zhou Yu2, Songqing Tang1, Lei Wang2, Xuetao Cao3, Taoyong Chen4.   

Abstract

Various pattern recognition receptors (PRRs) are activated in response to viral infection to stimulate the production of type I interferons (IFNs). However, central to the responses of all of these receptors is their activation of the kinase TBK1, which stimulates transcription by IFN regulatory factor 3 (IRF3). We investigated the mechanism by which the kinase activity of TBK1 is stimulated in response to viral infection. We found that the tyrosine kinase Src promoted the phosphorylation of TBK1 on Tyr179 upon viral infection of RAW264.7 macrophages. Mutation of Tyr179 to alanine resulted in impaired autophosphorylation of TBK1 at Ser172, which is required for TBK1 activation. The TBK1 Y179A mutant failed to rescue type I IFN production by virally infected RAW264.7 macrophages deficient in TBK1. Pharmacological inhibition of Src with AZD0530 and clustered regularly interspaced short palindromic repeats/Cas9-mediated knockout of Src demonstrated that Src was critical for activating the TBK1-IRF3 pathway and stimulating type I IFN production. However, Src did not directly bind to recombinant TBK1 in vitro but instead bound to the proline-X-X-proline motifs within key PRR adaptor proteins, such as TRIF, MAVS, and STING, which formed complexes with TBK1 after PRR engagement. Together, our data suggest that Src is the major tyrosine kinase that primes TBK1 for autophosphorylation and activation, thus providing mechanistic insights into the regulation of TBK1 activity by various PRRs as part of the innate antiviral response.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28049762     DOI: 10.1126/scisignal.aae0435

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  16 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

2.  TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.

Authors:  Jonathan M Cooper; Yi-Hung Ou; Elizabeth A McMillan; Rachel M Vaden; Aubhishek Zaman; Brian O Bodemann; Gurbani Makkar; Bruce A Posner; Michael A White
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

3.  Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.

Authors:  Qiang Zhang; Michael D Green; Weiping Zou; Meredith A Morgan; Xueting Lang; Jenny Lazarus; Joshua D Parsels; Shuang Wei; Leslie A Parsels; Jiaqi Shi; Nithya Ramnath; Daniel R Wahl; Marina Pasca di Magliano; Timothy L Frankel; Ilona Kryczek; Yu L Lei; Theodore S Lawrence
Journal:  Cancer Res       Date:  2019-05-17       Impact factor: 12.701

4.  The methyltransferase PRMT6 attenuates antiviral innate immunity by blocking TBK1-IRF3 signaling.

Authors:  Hua Zhang; Chaofeng Han; Tianliang Li; Nan Li; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2018-07-04       Impact factor: 11.530

5.  USP19 (ubiquitin specific peptidase 19) promotes TBK1 (TANK-binding kinase 1) degradation via chaperone-mediated autophagy.

Authors:  Xibao Zhao; Qianqian Di; Juan Yu; Jiazheng Quan; Yue Xiao; Huihui Zhu; Hongrui Li; Jing Ling; Weilin Chen
Journal:  Autophagy       Date:  2021-08-26       Impact factor: 13.391

6.  TBK1 Mediates Innate Antiviral Immune Response against Duck Enteritis Virus.

Authors:  Dongfang Wang; Hong Huo; Gebremeskel Mamu Werid; Yassein M Ibrahim; Lijie Tang; Yue Wang; Hongyan Chen
Journal:  Viruses       Date:  2022-05-09       Impact factor: 5.818

7.  Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Authors:  Cyril Pottier; Yingxue Ren; Ralph B Perkerson; Matt Baker; Gregory D Jenkins; Marka van Blitterswijk; Mariely DeJesus-Hernandez; Jeroen G J van Rooij; Melissa E Murray; Elizabeth Christopher; Shannon K McDonnell; Zachary Fogarty; Anthony Batzler; Shulan Tian; Cristina T Vicente; Billie Matchett; Anna M Karydas; Ging-Yuek Robin Hsiung; Harro Seelaar; Merel O Mol; Elizabeth C Finger; Caroline Graff; Linn Öijerstedt; Manuela Neumann; Peter Heutink; Matthis Synofzik; Carlo Wilke; Johannes Prudlo; Patrizia Rizzu; Javier Simon-Sanchez; Dieter Edbauer; Sigrun Roeber; Janine Diehl-Schmid; Bret M Evers; Andrew King; M Marsel Mesulam; Sandra Weintraub; Changiz Geula; Kevin F Bieniek; Leonard Petrucelli; Geoffrey L Ahern; Eric M Reiman; Bryan K Woodruff; Richard J Caselli; Edward D Huey; Martin R Farlow; Jordan Grafman; Simon Mead; Lea T Grinberg; Salvatore Spina; Murray Grossman; David J Irwin; Edward B Lee; EunRan Suh; Julie Snowden; David Mann; Nilufer Ertekin-Taner; Ryan J Uitti; Zbigniew K Wszolek; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; John R Hodges; Olivier Piguet; Ethan G Geier; Jennifer S Yokoyama; Robert A Rissman; Ekaterina Rogaeva; Julia Keith; Lorne Zinman; Maria Carmela Tartaglia; Nigel J Cairns; Carlos Cruchaga; Bernardino Ghetti; Julia Kofler; Oscar L Lopez; Thomas G Beach; Thomas Arzberger; Jochen Herms; Lawrence S Honig; Jean Paul Vonsattel; Glenda M Halliday; John B Kwok; Charles L White; Marla Gearing; Jonathan Glass; Sara Rollinson; Stuart Pickering-Brown; Jonathan D Rohrer; John Q Trojanowski; Vivianna Van Deerlin; Eileen H Bigio; Claire Troakes; Safa Al-Sarraj; Yan Asmann; Bruce L Miller; Neill R Graff-Radford; Bradley F Boeve; William W Seeley; Ian R A Mackenzie; John C van Swieten; Dennis W Dickson; Joanna M Biernacka; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2019-02-09       Impact factor: 17.088

8.  The uric acid crystal receptor Clec12A potentiates type I interferon responses.

Authors:  Kai Li; Konstantin Neumann; Vikas Duhan; Sukumar Namineni; Anne Louise Hansen; Tim Wartewig; Zsuzsanna Kurgyis; Christian K Holm; Mathias Heikenwalder; Karl S Lang; Jürgen Ruland
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

Review 9.  Roles of GSK-3 and β-Catenin in Antiviral Innate Immune Sensing of Nucleic Acids.

Authors:  Alexandre Marineau; Kashif Aziz Khan; Marc J Servant
Journal:  Cells       Date:  2020-04-07       Impact factor: 6.600

Review 10.  TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity.

Authors:  Cynthia Louis; Chris Burns; Ian Wicks
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.